Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Scientometric Analysis of Global Scientific Publications on Covid-19 and Diabetes With an Emphasis on Middle Eastern Countries Publisher



Atlasi R1 ; Tabatabaeimalazy O2 ; Larijani B1 ; Bandarian F3 ; Rezaei N4, 5 ; Khashayar P6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Medical Library & Information Sciences, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Medical Library & Information Sciences, School of Allied Medical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran
  6. 6. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom

Source: International Journal of Endocrinology and Metabolism Published:2022


Abstract

Background: Due to the worldwide spread of COVID-19, various countries have designed scientific studies on different aspects of the disease. Patients with diabetes mellitus (DM) have been proven to be at higher risk of COVID-19-related complications, hospital-ization, and death. Objectives: The aim was to conduct a scientometric analysis of scholarly outputs on diabetes and COVID-19. Methods: Web of Science was searched for scientific publications on diabetes and COVID-19 by Middle Eastern researchers until September 14, 2021. Collected data were analyzed for document type, subject area, countries, top journals, citation number, and authors’ collaboration network using VOS viewer 1.6.15 and bibliometrix R-package 4.1.1. Results: Overall, the characteristics of 603 documents on DM and COVID-19 were analyzed. The top three productive countries in the field were Iran, Turkey, and Saudi Arabia. The top affiliation was from Iran; “Tehran University of Medical Sciences” (n = 168), followed by Shahid Beheshti University of Medical Sciences (n = 82). The total citation number was 3704 times. The highest cited paper (348) was a systematic review from Iran, published in arch Acad Emerg Med. The top source was Diabetes & Metabolic Syndrome: Clinical Research & Reviews, with 26 documents. Conclusions: The current study provides an overview of the quantity and quality of published scholarly documents on the inter-section of DM and COVID-19 in the region. Our findings help scientists find the existing gaps, manage the research budgets, identify active authors and scientific institutes to collaborate with, and use their experience to produce new knowledge in the future. © 2022, International Journal of Endocrinology and Metabolism.
Related Docs
1. Pediatric Endocrinopathies Related to Covid-19: An Update, World Journal of Pediatrics (2023)
2. Commentary: A Human Pluripotent Stem Cell-Based Platform to Study Sars-Cov-2 Tropism and Model Virus Infection in Human Cells and Organoids, Frontiers in Endocrinology (2020)
3. Factors Associated With the Poor Outcomes in Diabetic Patients With Covid-19, Journal of Diabetes and Metabolic Disorders (2020)
4. Prediction of In-Hospital Mortality Rate in Covid-19 Patients With Diabetes Mellitus Using Machine Learning Methods, Journal of Diabetes and Metabolic Disorders (2023)
5. Scientometric Assessment of Scientific Documents Published in 2020 on Herbal Medicines Used for Covid-19, Journal of Herbal Medicine (2022)
6. Coronavirus Disease 2019 (Covid-19) in Pediatric Patients With Autoimmune Disorders, European Journal of Pediatrics (2023)
7. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
8. Covid-19 Infection Mortality Risk in Iranian Patients With Type 2 Diabetes, Hypertension and Obesity; [Risque De Mortalite Lie a L'infection Par La Covid-19 Chez Les Patients Iraniens Souffrant De Diabete De Type 2, D'hypertension Et D'obesite], Eastern Mediterranean Health Journal (2022)
Experts (# of related papers)
View all Related Experts
Hanieh-Sadat Ejtahed (1)
Parastoo Rostami (1)